GALECTIN THERAPEUTICS INC 4
4 · GALECTIN THERAPEUTICS INC · Filed Dec 19, 2016
Insider Transaction Report
Form 4
Greenberg Arthur
Director
Transactions
- Award
Stock option (right to buy)
2016-12-15+31,250→ 31,250 totalExercise: $0.89Exp: 2026-12-15→ Common stock (31,250 underlying)
Footnotes (1)
- [F1]The options vest 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting.